Cargando…
The Role of miR-181c in Mechanisms of Diabetes-Impaired Angiogenesis: An Emerging Therapeutic Target for Diabetic Vascular Complications
Diabetes mellitus is estimated to affect up to 700 million people by the year 2045, contributing to an immense health and economic burden. People living with diabetes have a higher risk of developing numerous debilitating vascular complications, leading to an increased need for medical care, a reduc...
Autores principales: | Solly, Emma L., Psaltis, Peter J., Bursill, Christina A., Tan, Joanne T. M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8414254/ https://www.ncbi.nlm.nih.gov/pubmed/34483928 http://dx.doi.org/10.3389/fphar.2021.718679 |
Ejemplares similares
-
The Role of High-Density Lipoproteins in Endothelial Cell Metabolism and Diabetes-Impaired Angiogenesis
por: Primer, Khalia R., et al.
Publicado: (2020) -
The regulation of miRNAs by reconstituted high-density lipoproteins in diabetes-impaired angiogenesis
por: Hourigan, Samuel T., et al.
Publicado: (2018) -
MicroRNAs as Therapeutic Targets and Clinical Biomarkers in Atherosclerosis
por: Solly, Emma L., et al.
Publicado: (2019) -
The Role of High-Density Lipoproteins in Diabetes and Its Vascular Complications
por: Wong, Nathan K. P., et al.
Publicado: (2018) -
Pro-Calcific Environment Impairs Ischaemia-Driven Angiogenesis
por: Mulangala, Jocelyne, et al.
Publicado: (2022)